At Quraxia Pharmaceuticals, we are driving innovation at the molecular level through our recombinant protein synthesis platform—a core capability that empowers the development of customized biologics, diagnostic reagents, vaccines, enzymes, and therapeutic proteins.

Our integrated facility is equipped for high-throughput molecular cloning, recombinant expression, and protein production in bacterial, yeast, and mammalian cell systems. We combine synthetic biology, protein engineering, and scalable expression systems to accelerate biotherapeutic R&D—from gene to functional protein.